Skip to Content

N 740 200 (Mexiletine 200 mg)

Pill with imprint N 740 200 is Orange, Capsule-shape and has been identified as Mexiletine hydrochloride 200 mg. It is supplied by Teva Pharmaceuticals USA.

Mexiletine is used in the treatment of diabetic peripheral neuropathy; arrhythmia; myotonia congenita; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for N 740 200

Mexiletine hydrochloride 200 mg N 740 200
Mexiletine hydrochloride 200 mg N 740 200
Mexiletine hydrochloride 200 mg N 740 200 Front
Mexiletine hydrochloride 200 mg N 740 200 Back

Mexiletine hydrochloride

N 740 200
200 mg
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
titanium dioxide
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0625 AvKare, Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.